Growth Metrics

Neogen (NEOG) Current Deferred Revenue (2021 - 2026)

Neogen has reported Current Deferred Revenue over the past 6 years, most recently at $3.9 million for Q1 2026.

  • For Q1 2026, Current Deferred Revenue fell 32.4% year-over-year to $3.9 million; the TTM value through Feb 2026 reached $3.9 million, down 32.4%, while the annual FY2025 figure was $5.6 million, 20.9% up from the prior year.
  • Current Deferred Revenue for Q1 2026 was $3.9 million at Neogen, up from $3.9 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $6.8 million in Q1 2023 and troughed at $3.8 million in Q3 2023.
  • A 5-year average of $5.1 million and a median of $5.5 million in 2022 define the central range for Current Deferred Revenue.
  • Biggest five-year swings in Current Deferred Revenue: surged 60.4% in 2022 and later crashed 32.4% in 2026.
  • Year by year, Current Deferred Revenue stood at $5.1 million in 2022, then decreased by 7.95% to $4.7 million in 2023, then grew by 20.77% to $5.7 million in 2024, then tumbled by 31.45% to $3.9 million in 2025, then grew by 0.67% to $3.9 million in 2026.
  • Business Quant data shows Current Deferred Revenue for NEOG at $3.9 million in Q1 2026, $3.9 million in Q4 2025, and $5.8 million in Q3 2025.